Markets
BSE See NSE See 49,099.99
-1,939.32 (-3.8%)

COVID-19 vaccine of Zydus Cadila gets nod to initiate human clinical trials

chinmayee d / Article rating: 4.9

The vaccine candidate ZyCov-D has been developed originally at the company’s research centre-Vaccine Technology Centre (VTC) in Ahmedabad, India. The vaccine when tested on animals brings out a strong immune response in multiple animal species like mice, rats, guinea pigs and rabbits. 

First4243444547495051Last

DSIJ MINDSHARE

12345Last

Knowledge

12